Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice

Pulmonary fibrosis (PF) is an age-related interstitial lung disease that results in notable morbidity and mortality. The Food and Drug Administration–approved drugs can decelerate the progression of PF; however, curing aged patients with severe fibrosis is ineffective because of insufficient accumul...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Meng-Meng, He, Xing-Yue, Tang, Ling, Qi, Liang, Yang, Ming-Yuan, Wang, Yi, Xing, Lei, Jeong, Jee-Heon, Jiang, Hu-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355834/
https://www.ncbi.nlm.nih.gov/pubmed/37467328
http://dx.doi.org/10.1126/sciadv.adg5358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355834/
https://www.ncbi.nlm.nih.gov/pubmed/37467328
http://dx.doi.org/10.1126/sciadv.adg5358

Ejemplares similares